| __timestamp | Amphastar Pharmaceuticals, Inc. | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 21263000 |
| Thursday, January 1, 2015 | 37065000 | 18890000 |
| Friday, January 1, 2016 | 41199000 | 15295000 |
| Sunday, January 1, 2017 | 43415000 | 12944000 |
| Monday, January 1, 2018 | 57564000 | 13599000 |
| Tuesday, January 1, 2019 | 68853000 | 30391000 |
| Wednesday, January 1, 2020 | 67229000 | 13020000 |
| Friday, January 1, 2021 | 60932000 | 16287000 |
| Saturday, January 1, 2022 | 74771000 | 19943000 |
| Sunday, January 1, 2023 | 73741000 | 21042000 |
In pursuit of knowledge
In the competitive landscape of biotechnology and pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. From 2014 to 2023, Amphastar Pharmaceuticals, Inc. has consistently outpaced Vericel Corporation in R&D investment. Amphastar's R&D expenses grew by approximately 160%, peaking in 2022 with a 26% increase from the previous year. In contrast, Vericel's R&D spending showed a more modest growth of around 10% over the same period, with a notable spike in 2019. This strategic focus on R&D by Amphastar suggests a robust pipeline and a strong commitment to future growth. Meanwhile, Vericel's steady investment reflects a more conservative approach, potentially focusing on optimizing existing products. As the industry evolves, these spending patterns may significantly influence each company's market position and innovation capabilities.
Bristol-Myers Squibb Company vs Amphastar Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Regeneron Pharmaceuticals, Inc. vs Vericel Corporation
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Vericel Corporation
United Therapeutics Corporation or Vericel Corporation: Who Invests More in Innovation?
Intra-Cellular Therapies, Inc. or Vericel Corporation: Who Invests More in Innovation?
R&D Insights: How Insmed Incorporated and Amphastar Pharmaceuticals, Inc. Allocate Funds
R&D Insights: How Jazz Pharmaceuticals plc and Vericel Corporation Allocate Funds
Research and Development Expenses Breakdown: Lantheus Holdings, Inc. vs Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Axsome Therapeutics, Inc. vs Amphastar Pharmaceuticals, Inc.
Comparing Innovation Spending: Rhythm Pharmaceuticals, Inc. and Vericel Corporation
Who Prioritizes Innovation? R&D Spending Compared for Vericel Corporation and Soleno Therapeutics, Inc.
Amphastar Pharmaceuticals, Inc. vs Evotec SE: Strategic Focus on R&D Spending